Cyclomics
Epinn
Next generation Tumor classification
Our Methylation based software enables clinicians to make the right decicion for patients in record-breaking time. Brain tumor classification can be done routinely in less than 90 minutes. From sample to result. Using minimal equipment already present in the hospital. At accuracies > 99%. This has real impact, even during surgery, improving patient outcomes and wellbeeing.
Advantages of Epinn
Epinn allows you to run state-of-the-art tumor classification and copy number analysis, no advanced skills required. More advantages:
-
Local: no sample data leaves your machine. Giving you full control over your data.
-
Secure: Prioritizes data security.
-
Real-time: Get feedback about the classification at every sinle step of the process
-
Fast: Epinn runs multithreaded on your machine.
-
Accurate: Use the latests models with the highest accuracy.
-
Intuitive: User-friendly interface designed for ease of use.
Current models
More in the works
We are hard at work to expand!
Status:
Epinn-OSCC
Classifing oral squamous cell carcinoma samples based on methylation patterns.
Status:
Epinn-CNS
Our improved version of sturgeon to classifiy central nerveous system tumor biopsies.
Status:
Sturgeon
The original, Nature published, Metylation based predicition model.
Status:
In the Media
Nature
11 oktober 2023
Ultra-fast deep-learned CNS tumour classification during surgery
Sturgeon
Nat Geo
15 oktober 2024
Meet Sturgeon, the AI tool that helps doctors identify brain tumors faster than ever
Sturgeon
.png)
